SHELLEY GAUM: Open Payments
NPI 1720396872 · SOUTH CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 46 payments from 11 companies in 2025. Trend: 2023 $399 · 2024 $842 · 2025 $837
Food & beverage: $823Education: $15
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $250 |
| ABBVIE INC. | 11 | $210 |
| Novo Nordisk Inc | 7 | $141 |
| Sage Therapeutics, LLC | 3 | $72 |
| Exact Sciences Corporation | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Becton, Dickinson and Company | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: GEMTESA, MYFEMBREE, UBRELVY, QULIPTA, Ozempic, ZURZUVAE, VRAYLAR, Cologuard Collection Kit.
Industry payments across WV — which companies pay providers there.
